Litcius/Paper detail

Serial assessment of measurable residual disease in medulloblastoma liquid biopsies

Anthony P. Y. Liu, Kyle Smith, Rahul Kumar, Leena Paul, Laure Bihannic, Tong Lin, Kendra K. Maaß, Kristian W. Pajtler, Murali Chintagumpala, Jack M. Su, Éric Bouffet, Michael J. Fisher, Sridharan Gururangan, Richard J. Cohn, Tim Hassall, Jordan R. Hansford, Paul Klimo, Frederick A. Boop, Clinton F. Stewart, Julie H. Harreld, Thomas E. Merchant, Ruth Tatevossian, Geoffrey Neale, Matthew Lear, Jeffery M. Klco, Brent A. Orr, David W. Ellison, Richard J. Gilbertson, Arzu Onar‐Thomas, Amar Gajjar, Giles Robinson, Paul A. Northcott

2021Cancer Cell180 citationsDOIOpen Access PDF

Topics & Concepts

MedulloblastomaMedicineMinimal residual diseaseBiomarkerOncologyLiquid biopsyInternal medicineProspective cohort studyCerebrospinal fluidSurrogate endpointPathologyCancerBiologyBone marrowBiochemistryCancer Genomics and DiagnosticsGlioma Diagnosis and TreatmentSingle-cell and spatial transcriptomics